David Casadevall

697 total citations
31 papers, 383 citations indexed

About

David Casadevall is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, David Casadevall has authored 31 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in David Casadevall's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (7 papers). David Casadevall is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (7 papers). David Casadevall collaborates with scholars based in Spain, United States and Italy. David Casadevall's co-authors include Joan Albanell, Álvaro Taus, Edurne Arriola, Sílvia Menéndez, Sergi Clavé, Lara Pijuán, Marta Salido, Marta Lorenzo, Joaquim Bellmunt and Blanca Espinet and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Clinical Cancer Research.

In The Last Decade

David Casadevall

26 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Casadevall Spain 9 233 134 116 69 60 31 383
Sergi Clavé Spain 10 207 0.9× 221 1.6× 117 1.0× 76 1.1× 33 0.6× 26 365
Erik Škof Slovenia 11 173 0.7× 48 0.4× 44 0.4× 60 0.9× 29 0.5× 34 347
An Hsu Taiwan 6 116 0.5× 56 0.4× 136 1.2× 135 2.0× 34 0.6× 7 369
Sidrah Shah United Kingdom 9 168 0.7× 97 0.7× 102 0.9× 128 1.9× 31 0.5× 11 371
Xia He China 10 173 0.7× 132 1.0× 58 0.5× 37 0.5× 14 0.2× 13 322
Núria Baixeras Spain 11 111 0.5× 78 0.6× 36 0.3× 111 1.6× 63 1.1× 24 326
J. Garde Spain 11 196 0.8× 168 1.3× 84 0.7× 49 0.7× 15 0.3× 54 339
Alberto Villanueva Spain 8 163 0.7× 38 0.3× 56 0.5× 176 2.6× 23 0.4× 12 419
Nanyan Rao China 12 176 0.8× 55 0.4× 163 1.4× 33 0.5× 13 0.2× 26 373
Jiannan Wu China 11 191 0.8× 50 0.4× 162 1.4× 68 1.0× 26 0.4× 18 351

Countries citing papers authored by David Casadevall

Since Specialization
Citations

This map shows the geographic impact of David Casadevall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Casadevall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Casadevall more than expected).

Fields of papers citing papers by David Casadevall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Casadevall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Casadevall. The network helps show where David Casadevall may publish in the future.

Co-authorship network of co-authors of David Casadevall

This figure shows the co-authorship network connecting the top 25 collaborators of David Casadevall. A scholar is included among the top collaborators of David Casadevall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Casadevall. David Casadevall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foote, Michael B., James R. White, Walid K. Chatila, et al.. (2024). Analysis of Shared Variants between Cancer Biospecimens. Clinical Cancer Research. 31(2). 376–386.
2.
Larrainzar‐Garijo, Ricardo, Judith Marín‐Corral, David Casadevall, et al.. (2024). Predictive model for a second hip fracture occurrence using natural language processing and machine learning on electronic health records. Scientific Reports. 14(1). 532–532. 3 indexed citations
3.
Menéndez, Sílvia, David López, Beatríz Bellosillo, et al.. (2023). Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells. Human Pathology. 139. 91–105. 5 indexed citations
4.
Segura, Tomás, Ignacio Hernández Medrano, Carlos Del Rio‐Bermudez, et al.. (2023). Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence. Scientific Reports. 13(1). 702–702. 15 indexed citations
5.
6.
Casadevall, David, Joan Albanell, Margarita Posso, et al.. (2022). Exploring the Association of Cancer and Depression in Electronic Health Records: Combining Encoded Diagnosis and Mining Free-Text Clinical Notes. JMIR Cancer. 8(3). e39003–e39003. 2 indexed citations
7.
Casadevall, David, Sara García‐Alonso, Sílvia Menéndez, et al.. (2022). mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer. Molecular Cancer Research. 20(7). 1108–1121. 15 indexed citations
8.
Vidal, Joana, David Casadevall, Beatríz Bellosillo, et al.. (2021). Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial. Clinical Cancer Research. 27(10). 2890–2898. 62 indexed citations
9.
Casadevall, David, et al.. (2020). Circulating Tumor Cells: Applications for Early Breast Cancer. Advances in experimental medicine and biology. 1220. 135–146. 6 indexed citations
10.
Seguí, Elia, Édouard Auclin, David Casadevall, et al.. (2020). 1714P Change of circulating pro-inflammatory markers between pre-COVID-19 condition and COVID-19 diagnosis predicts early death in cancer patients: The FLARE score. Annals of Oncology. 31. S1008–S1008. 1 indexed citations
11.
Seguí, Elia, Marta García de Herreros, Édouard Auclin, et al.. (2020). 1681P First results of the COCO study: COVID-19 outcomes in patients with cancer. Annals of Oncology. 31. S996–S996.
12.
Rocha, Pedro, Mayra Orrillo, Álvaro Taus, et al.. (2020). Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC. JTO Clinical and Research Reports. 2(1). 100115–100115. 3 indexed citations
13.
Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2017). P1.02-048 MET Exon 14 Skipping Mutations and Gene Amplifications Are Not Simultaneous Events in NSCLC. Journal of Thoracic Oncology. 12(1). S516–S517. 1 indexed citations
14.
Taus, Álvaro, Ainhoa Hernández, Eva López, et al.. (2017). P1.02-039 Assessment of KRAS mutations (by Digital PCR) in Circulating Tumoral DNA from Lung Adenocarcinoma Patients. Journal of Thoracic Oncology. 12(1). S511–S511. 1 indexed citations
15.
Casadevall, David, et al.. (2017). The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review. Cancer Treatment Reviews. 61. 82–93. 23 indexed citations
16.
Casadevall, David, Sergi Clavé, Álvaro Taus, et al.. (2017). Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples. Clinical Lung Cancer. 18(6). 682–691.e5. 69 indexed citations
17.
Clavé, Sergi, David Casadevall, Lara Pijuán, et al.. (2016). 4P Co-amplifications of PD-L1/PD-L2 genes (9p24.1) and PD-L1 protein expression in NSCLC patients. Journal of Thoracic Oncology. 11(4). S58–S58. 2 indexed citations
18.
Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2016). 11P Prognostic impact of MET mutations in exon 14 and copy number alterations in a series of NSCLC patients. Journal of Thoracic Oncology. 11(4). S61–S61. 1 indexed citations
19.
Arriola, Edurne, Álvaro Taus, & David Casadevall. (2015). Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?. World Journal of Clinical Oncology. 6(4). 45–45. 4 indexed citations
20.
Casadevall, David, Javier Gimeno, Sergi Clavé, et al.. (2015). MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC). Oncotarget. 6(18). 16215–16226. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sergi Clavé Breakdown of academic impact, for papers by Erik Škof Breakdown of academic impact, for papers by An Hsu Breakdown of academic impact, for papers by Sidrah Shah Breakdown of academic impact, for papers by Xia He Breakdown of academic impact, for papers by Núria Baixeras Breakdown of academic impact, for papers by J. Garde Breakdown of academic impact, for papers by Alberto Villanueva Breakdown of academic impact, for papers by Nanyan Rao Breakdown of academic impact, for papers by Jiannan Wu
Rankless by CCL
2026